Transaction overview
San Raffaele spa acquired Nomentana Hospital, a private healthcare facility located in Rome's Fonte Nuova district, on April 14, 2026. The terms of the deal were not disclosed, but San Raffaele spa purchased 100% ownership of the hospital. PwC served as the financial advisor to Nomentana Hospital during this transaction.
Deal structure and financing
Details regarding the equity and debt split for this acquisition are unavailable. PwC was involved as the lead financial advisor to Nomentana Hospital, providing valuation services and financial assistance in executing the deal. The lack of disclosed terms means no information is available on leverage metrics or lock-up periods for seller-retained stakes. Additionally, there is no indication of IPO optionality or specific financing details from any other sources.
Strategic context
San Raffaele spa's acquisition of Nomentana Hospital aligns with its strategy to expand its footprint in the Italian private healthcare sector. With San Raffaele spa being a prominent player in this market, the addition of Nomentana Hospital enhances their service offerings and geographic reach. The rationale for Nomentana Hospital’s divestiture is tied to a negotiated composition process, indicating potential financial restructuring or consolidation objectives by the seller.
Regulatory path
No specific regulatory approvals were announced for this transaction as of April 14, 2026. Given the nature of healthcare M&A in Italy, it is likely that the Italian Ministry of Health and possibly the Antitrust Authority (AGCM) reviewed aspects of the deal. The absence of public information suggests that any necessary regulatory clearances were either not required or were obtained through standard internal procedures without formal announcements.